Upgrades and Downgrades for Friday 2/16


  • Calithera Biosciences (CALA) upgraded by Citi from Neutral to Buy
  • Volaris (VLRS) upgraded by UBS from Neutral to Buy
  • Avianca (AVH) upgraded by UBS from Sell to Neutral
  • Allison Transmission (ALSN) upgraded by Stifel from Hold to Buy
  • Omnicom (OMC) upgraded by Macquarie from Underperform to Neutral
  • Cowen Group (COWN) upgraded by Nomura Instinet from Neutral to Buy
  • Wendy’s (WEN) upgraded by Guggenheim from Neutral to Buy
  • Equity Commonwealth (EQC) upgraded by Stifel from Hold to Buy
  • Blue Apron (APRN) upgraded by Northcoast from Sell to Neutral
  • Acorda Therapeutics (ACOR) upgraded by Piper Jaffray from Neutral to Overweight


  • Airgain (AIRG) downgraded by B. Riley FBR from Buy to Neutral
  • Allison Transmission (ALSN) downgraded by JPMorgan from Neutral to Underweight
  • A. Schulman (SHLM) downgraded by Longbow from Buy to Neutral
  • Amber Road (AMBR) downgraded by Canaccord from Buy to Hold
  • Kimco Realty (KIM) downgraded by BofA/Merrill from Buy to Neutral
  • Dr Pepper Snapple (DPS) downgraded by Jefferies from Buy to Hold
  • Bio-Rad (BIO) downgraded by CL King from Buy to Neutral
  • Pacira (PCRX) downgraded by Needham from Buy to Hold
  • Oil States (OIS) downgraded by Evercore ISI from Outperform to In Line
  • Parker Drilling (PKD) downgraded by Evercore ISI from Outperform to In Line

fly360Upgrades & Downgrades provided by The Fly at http://www.thefly.com.  The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of TheFly’s services FREE for 14 days by clicking here.